DUKE UNIVERSITY
Genetic engineering of kidney allografts by ex vivo perfusion delivery of adeno-associated viral vectors
Genetic engineering of kidney allografts by ex vivo perfusion delivery of adeno-associated viral vectors is a funding opportunity from DUKE UNIVERSITY, up to 466043, closing April 30, 2027.
Apr 30, 2027
(273d left)Overview
Abstract Despite advances in many domains, the field of solid organ transplantation remains limited by two distinct but connected problems: (1) a critical shortage of donor organs and (2) suboptimal graft longevity due to chronic alloimmune-mediated injury. For patients with end-stage renal disease, these limitations…